ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HPC Hyrdation Pharmaceuticals Company Ltd

0.013
0.00 (0.00%)
May 22 2024 - Closed
Delayed by 20 minutes

Hyrdation Pharmaceuticals Financial Summary

The current HPC market cap is 3.45M. The company's latest EPS is USD -0.0306 and P/E is -0.33.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.96M6.57M6.13M9.1M10.04M
Operating Income -3.4M-485k-7.5M-10.7M-7.74M
Net Income -3.43M-744k-8.95M-10.61M-8.1M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 4.2M4.45M15.31M10.39M6.69M
Total Liabilities 1.81M2.44M2.08M6.41M7.05M
Total Equity 2.39M2M13.23M3.98M-358k

Cash Flow

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -2.78M-3.86M-8.08M-9.75M-5.73M
Investing -20k2.73M N/A N/A N/A
Financing 3.04M N/A 17.03M4.08M2.72M
Market Cap 3.45M
Price to Earnings Ratio -0.33
Price to Sales Ratio 0.26
Price to Cash Ratio 1.45
Price to Book Ratio -7.41
Dividend Yield -

Share Statistics

Shares Outstanding 265.14M
Average Volume (1 week) 393.87k
Average Volume (1 Month) 220.83k
52 Week Change -80.30%
52 Week High 0.066
52 Week Low 0.012
Spread (Intraday) 0 (7.14%)

Company Info

Company Name Hyrdation Pharmaceuticals Company Ltd
Address level 42
melbourne, victoria 3000
Website https://hydralyte.com
Industry drugs and proprietary-whsl (5122)

Your Recent History

Delayed Upgrade Clock